WELCORPNSEWelspun Corp Limited· Industrial ProductsHighPositive
Announced Fri, 8 Aug, 2025 · 20:07 IST

Welspun Corp Limited has informed the Exchange about CARE Ratings upgrades its rating on the Company s Long Term Bank Facilities and Non-Convertible Debentures

Rating UpgradedDebt PrepaidCredit & Debt View source PDFExplain this filing

WELCORP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.1%Reaction day
₹866.00
prior close
₹866.60
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.5%-0.6% vs market
Iron & Steel Products peers, median of 90sector-0.0%-0.1% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Smallcap 250 and 0.1 pts less than its Iron & Steel Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.8
10m
+0.4
15m
+0.4
30m
-0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.1+0.5-0.6-0.0-0.1
Next day
+1.4+0.5+0.9+0.0+1.4
2d
+1.9+1.1+0.8-0.3+2.2
3d
+1.3+0.7+0.6-0.7+2.0
4d
+1.3+2.0-0.7-1.1+2.4
5d
+1.4+2.8-1.4+0.1+1.3
1w
+3.2+3.2-0.0+0.3+2.9
15d
-1.6+2.6-4.3-0.1-1.5
1m
+0.5+3.3-2.8-0.8+1.3
2m
-2.4+3.2-5.6-3.1+0.6
3m
+6.2+2.7+3.5-3.6+9.8
UpDownMarket · Nifty Smallcap 250Sector · Iron & Steel Products peers, median of 90Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

CARE Ratings upgraded Welspun Corp's long-term bank facilities (₹1,059 crore) and non-convertible debentures (₹240 crore) from 'CARE AA; Positive' to 'CARE AA+; Stable', while reaffirming short-term facilities (₹5,709 crore) and commercial paper (₹500 crore) at 'CARE A1+'. The upgrade reflects improved financial health: overall gearing dropped from 0.61x to 0.36x, term loans fell sharply from ₹1,533 crore (FY24) to ₹491 crore (FY25), and the company holds a net cash position of ₹600 crore as of Q1FY26. Order book nearly tripled to ₹19,000 crore in July 2025, driven by over ₹10,000 crore in US orders during FY25, providing strong revenue visibility for FY26-FY27. FY25 revenue was ₹13,948 crore with PBILDT margin expanding further to 14.78% in Q1FY26 from 11.86% in FY25, helped by a higher mix of value-added DI pipes.

Likely market impact

Positive for shareholders — the rating upgrade signals strengthening creditworthiness, likely leading to lower borrowing costs, and the robust ₹19,000 crore order book plus improving margins support earnings visibility over the next two years.